Filing Details

Accession Number:
0001827672-23-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-25 17:12:54
Reporting Period:
2023-08-23
Accepted Time:
2023-08-25 17:12:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819790 Tarsus Pharmaceuticals Inc. TARS Biological Products, (No Disgnostic Substances) (2836) 814717861
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827672 R. Bobak Azamian C/O Tarsus Pharmaceuticals, Inc.
15440 Laguna Canyon Road, Suite 160
Irvine CA 92618
President/Ceo And Board Chair Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-08-23 8,000 $17.23 902,106 No 4 S Indirect By the Bobak Azamian Living Trust established April 16, 2018
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By the Bobak Azamian Living Trust established April 16, 2018
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,597 Direct
Footnotes
  1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023.
  2. The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.00 to $17.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.